Marie Anne Pringle

Marie Anne Pringle

Auto-generated profile, based on publicly available information

Marie Anne Pringle

Institute of Molecular, Cell and Systems Biology, College of Medical Veterinary and Life Sciences, Davidson Building, University of Glasgow, Glasgow, G12 8QQ, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2003 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
TSTorstein Stein
Torstein Stein
JMJoanna S Morris
Joanna S Morris
CDClaire R Davies
Claire R Davies
SWStephen J Weber-Hall
Stephen J Weber-Hall
MDMarie-Anne Duffy
Marie-Anne Duffy
BGBarry A Gusterson
Barry A Gusterson
Involution of the mammary gland is a complex process of controlled apoptosis and tissue remodelling. The aim of the project was to identify genes that are specifically involved in this process. We used Affymetrix oligonucleotide microarrays to perform a detailed transcript analysis on the mechanism of controlled involution after withdrawal of the pups at day seven of lactation. Some of the results were confirmed by semi-quantitative reverse transcriptase polymerase chain reaction, Western blotting or immunohistochemistry. We identified 145 genes that were specifically upregulated during the first 4 days of involution; of these, 49 encoded immunoglobulin genes. A further 12 genes, including those encoding the signal transducer and activator of transcription 3 (STAT3), the lipopolysaccharide receptor (CD14) and lipopolysaccharide-binding protein (LBP), were involved in the acute-phase response, demonstrating that the expression of acute-phase response genes can occur in the mammary gland itself and not only in the liver. Expression of LBP and CD14 was upregulated, at both the RNA and protein level, immediately after pup withdrawal; CD14 was strongly expressed in the luminal epithelial cells. Other genes identified suggested neutrophil activation early in involution, followed by macrophage activation late in the process. Immunohistochemistry and histological staining confirmed the infiltration of the involuting mammary tissue with neutrophils, plasma cells, macrophages and eosinophils. Oligonucleotide microarrays are a useful tool for identifying genes that are involved in the complex developmental process of mammary gland involution. The genes identified are consistent with an immune cascade, with an early acute-phase response that occurs in the mammary gland itself and resembles a wound healing process.

1 June 2013 in Molecular Cell
Verified
Journal Article
Open access
OOOjore Benedict Valentine Oka
Ojore Benedict Valentine Oka
MPMarie Anne Pringle
Marie Anne Pringle
ISIsabel Myriam Schopp
Isabel Myriam Schopp
IBIneke Braakman
Ineke Braakman
NBNeil Bulleid
Neil Bulleid
ERdj5 is a member of the protein disulfide isomerase family of proteins localized to the endoplasmic reticulum (ER) of mammalian cells. To date, only a limited number of substrates for ERdj5 are known. Here we identify a number of endogenous substrates that form mixed disulfides with ERdj5, greatly expanding its client repertoire. ERdj5 previously had been thought to exclusively reduce disulfides in proteins destined for dislocation to the cytosol for degradation. However, we demonstrate here that for one of the identified substrates, the low-density lipoprotein receptor (LDLR), ERdj5 is required not for degradation, but rather for efficient folding. Our results demonstrate that the crucial role of ERdj5 is to reduce non-native disulfides formed during productive folding and that this requirement is dependent on its interaction with BiP. Hence, ERdj5 acts as the ER reductase, both preparing misfolded proteins for degradation and catalyzing the folding of proteins that form obligatory non-native disulfides.

17 June 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
OOOjore Bv Oka
Ojore Bv Oka
MLMarcel van Lith
Marcel van Lith
JRJana Rudolf
Jana Rudolf
WTWanida Tungkum
Wanida Tungkum
MPMarie Anne Pringle
Marie Anne Pringle
NBNeil Bulleid
Neil Bulleid
Activation of the ATF6α signaling pathway is initiated by trafficking of ATF6α from the ER to the Golgi apparatus. Its subsequent proteolysis releases a transcription factor that translocates to the nucleus causing downstream gene activation. How ER retention, Golgi trafficking, and proteolysis of ATF6α are regulated and whether additional protein partners are required for its localization and processing remain unresolved. Here, we show that ER‐resident oxidoreductase ERp18 associates with ATF6α following ER stress and plays a key role in both trafficking and activation of ATF6α. We find that ERp18 depletion attenuates the ATF6α stress response. Paradoxically, ER stress accelerates trafficking of ATF6α to the Golgi in ERp18‐depleted cells. However, the translocated ATF6α becomes aberrantly processed preventing release of the soluble transcription factor. Hence, we demonstrate that ERp18 monitors ATF6α ER quality control to ensure optimal processing following trafficking to the Golgi.

1 August 2010 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
KBKaren Blyth
Karen Blyth
FVFrancois Vaillant
Francois Vaillant
AJAlma Jenkins
Alma Jenkins
LMLaura McDonald
Laura McDonald
MPMarie Anne Pringle
Marie Anne Pringle
ECEwan R. Cameron
Ewan R. Cameron

16 January 2017 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GPGreg J Poet
Greg J Poet
OOOjore Bv Oka
Ojore Bv Oka
MLMarcel van Lith
Marcel van Lith
ZCZhenbo Cao
Zhenbo Cao
PRPhilip Robinson
Philip Robinson
NBNeil Bulleid
Neil Bulleid
Folding of proteins entering the secretory pathway in mammalian cells frequently requires the insertion of disulfide bonds. Disulfide insertion can result in covalent linkages found in the native structure as well as those that are not, so‐called non‐native disulfides. The pathways for disulfide formation are well characterized, but our understanding of how non‐native disulfides are reduced so that the correct or native disulfides can form is poor. Here, we use a novel assay to demonstrate that the reduction in non‐native disulfides requires NADPH as the ultimate electron donor, and a robust cytosolic thioredoxin system, driven by thioredoxin reductase 1 (TrxR1 or TXNRD1). Inhibition of this reductive pathway prevents the correct folding and secretion of proteins that are known to form non‐native disulfides during their folding. Hence, we have shown for the first time that mammalian cells have a pathway for transferring reducing equivalents from the cytosol to the ER, which is required to ensure correct disulfide formation in proteins entering the secretory pathway.

1 November 2010 in The American Journal of Pathology
Verified
Journal Article
Closed access
TSTorstein Stein
Torstein Stein
ECEmilio Cosimo
Emilio Cosimo
XYXinzi Yu
Xinzi Yu
PSPaul R. Smith
Paul R. Smith
RSRonald Simon
Ronald Simon
BGBarry A. Gusterson
Barry A. Gusterson